The global veterinary infectious disease diagnostics market is projected to witness significant growth over the coming decade. Estimated at USD 1.9 billion in 2023, the market is forecast to surpass USD 4.9 billion by 2033, registering a robust compound annual growth rate (CAGR) of 10.1% during the forecast period. This growth reflects increasing attention toward animal health, driven by the rise in zoonotic diseases and demand for preventive diagnostics.
The veterinary infectious disease diagnostics sector has become indispensable in modern veterinary medicine. Tools for early and accurate detection of diseases in animals play a critical role in ensuring animal welfare, safeguarding food supply chains, and preventing disease outbreaks that could affect both animals and humans. The market’s growth is underpinned by the adoption of advanced diagnostic technologies and heightened awareness of the economic and health impacts of infectious diseases in livestock and companion animals.
Governments, veterinary organizations, and market players are increasingly prioritizing the development and accessibility of diagnostic solutions. Molecular diagnostics, rapid tests, and point-of-care technologies are gaining traction, offering quicker and more precise results to veterinarians and livestock managers. Additionally, the rise in pet ownership globally and the growing demand for pet insurance are further propelling the market forward.
Key Takeaways:
- The veterinary infectious disease diagnostics market is expected to grow from USD 1.9 billion in 2023 to over USD 4.9 billion by 2033, at a CAGR of 10.1%.
- Rising incidences of zoonotic diseases and the need for preventive diagnostics are key market drivers.
- Technological advancements such as molecular diagnostics and rapid testing solutions are reshaping the market landscape.
- Increased pet ownership and awareness of animal health are contributing to market growth globally.
Global Trends & Scopes Transforming the Veterinary Infectious Disease Diagnostics Market
With diagnostic innovation, key players are devoted to providing a better experience for customers. Veterinarians may reliably obtain full diagnostic insights anytime, anywhere, thanks to artificial intelligence (AI) algorithms that provide cost-effective access to expert-level results, remote veterinary specialist evaluation, and post-diagnostic consultations.
Their unique product and service combination provides a full picture, allowing veterinarians to make faster, more educated medical decisions for more tailored treatment. They see their veterinarian clients as partners in their goal. As a result, they are keen to customize their services to the demands of the end user, tailoring their solutions to fit inside – and improve – their existing protocols.
The veterinary microbiology solutions given by key companies are designed with veterinary labs in mind and comprise a full variety of high-quality culture mediums, identification, and susceptibility testing items. It also has automated Johne’s Disease instruments and reagents.
Request a Sample of this Report Now: https://www.fmisamplereport.com/sample/rep-gb-14276
Key Companies Revamping the Veterinary Infectious Disease Diagnostics Market Space
Due to the presence of multiple established competitors, the veterinary infectious disease diagnostics market share is very competitive. To capitalize on market growth potential, these firms are focusing on increasing their reach through acquisitions, expansions, product approvals, and launches.
Recent Developments:
- In July 2018, Zoetis Inc. announced the completion of its acquisition of Abaxis, a manufacturer and developer of diagnostic devices for veterinary point-of-care use.
- In November 2021, with the acquisition of DMV Imaging, FUJIFILM Europe hopes to extend its veterinary diagnostic client offering with products and services. DMV Imaging, based in Lyon, France, has specialized in providing veterinary point-of-care laboratory diagnostics.
- In March 2021, TRUFORMA was formally launched into commercialization by Zomedica Corp., a veterinary health firm that manufactures point-of-care diagnostics devices for cats and dogs.
- In September 2021, Heska Corporation purchased a controlling ownership in Biotech Laboratories U.S.A. LLC, which is a pioneer in fast assay diagnostics testing. Biotech Laboratories U.S.A. LLC strives to make animals healthy by delivering high-quality diagnostic solutions to veterinarians, livestock producers, and pet owners across the world.
Key Market Players
- Zoetis Inc.
- Thermo Fisher Scientific
- Virbac
- Biomerieux SA
- Heska Corporation
- IDvet
- NEOGEN Corporation
- QIAGEN N.V.
- Randox Laboratories Ltd.
Key Segments Profiled in the Veterinary Infectious Disease DiagnosticsMarket Survey
By Technology:
- Immunodiagnostics
- Molecular Diagnostic
- Others
By Animal Type:
- Companion Animal
- Food-producing Animals
By End User:
- Reference Laboratories
- Veterinary Hospitals & Clinics
- Point-of-Care
- Research Institutes & Universities
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube